Elizabeth E. Reed, Chief Legal Officer and GC at Travere Therapeutics, Inc. (TVTX), sold 2,994 shares at $32.74 ($96K) on 2026-02-04, disclosed to the SEC on 2026-02-05.
Scheduled sale ($96k) by Chief Legal Officer and GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.07 | 2,485 | $80K | 82.7% |
| 2 | $32.74 | 509 | $17K | 17.3% |
| Total | $32.18 avg | 2,994 | $96K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.1M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $300K | — | Filing → |
| TVTX | SELL | 2026-03-18 | $562K | — | Filing → |